![Vincent Wong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vincent Wong
Directeur/Bestuurslid bij BIONANO GENOMICS, INC.
Profiel
Mr. Vincent J.
Wong is an Independent Director at Bionano Genomics, Inc. He is on the Board of Directors at Bionano Genomics, Inc. Mr. Wong was previously employed as a Chief Commercial Officer by Geneoscopy, Inc. He received his undergraduate degree from the University of Notre Dame, a graduate degree from Indiana University Maurer School of Law and an MBA from Kellogg School of Management.
Actieve functies van Vincent Wong
Bedrijven | Functie | Begin |
---|---|---|
BIONANO GENOMICS, INC. | Directeur/Bestuurslid | 22-12-2021 |
Eerdere bekende functies van Vincent Wong
Bedrijven | Functie | Einde |
---|---|---|
Geneoscopy, Inc.
![]() Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Corporate Officer/Principal | 01-01-2024 |
Opleiding van Vincent Wong
University of Notre Dame | Undergraduate Degree |
Indiana University Maurer School of Law | Graduate Degree |
Kellogg School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIONANO GENOMICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Geneoscopy, Inc.
![]() Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Commercial Services |